Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Revenue (2016 - 2025)

Historic Revenue for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $75.1 million.

  • Medifast's Revenue fell 3689.57% to $75.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $385.8 million, marking a year-over-year decrease of 3596.49%. This contributed to the annual value of $385.8 million for FY2025, which is 3596.49% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Revenue is $75.1 million, which was down 3689.57% from $89.4 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Revenue ranged from a high of $453.3 million in Q2 2022 and a low of $75.1 million during Q4 2025
  • Over the past 5 years, Medifast's median Revenue value was $266.0 million (recorded in 2023), while the average stood at $259.2 million.
  • In the last 5 years, Medifast's Revenue surged by 9089.27% in 2021 and then tumbled by 4992.91% in 2024.
  • Medifast's Revenue (Quarter) stood at $377.8 million in 2021, then dropped by 10.74% to $337.2 million in 2022, then tumbled by 43.36% to $191.0 million in 2023, then tumbled by 37.7% to $119.0 million in 2024, then plummeted by 36.9% to $75.1 million in 2025.
  • Its Revenue stands at $75.1 million for Q4 2025, versus $89.4 million for Q3 2025 and $105.6 million for Q2 2025.